LSV Asset Management Purchases 540,400 Shares of Clarivate PLC $CLVT

LSV Asset Management raised its stake in Clarivate PLC (NYSE:CLVT) by 25.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,647,900 shares of the company’s stock after acquiring an additional 540,400 shares during the period. LSV Asset Management’s holdings in Clarivate were worth $8,844,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in CLVT. Royal Bank of Canada increased its holdings in Clarivate by 96.2% during the first quarter. Royal Bank of Canada now owns 63,630 shares of the company’s stock worth $250,000 after buying an additional 31,197 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of Clarivate by 37.0% in the first quarter. AQR Capital Management LLC now owns 451,872 shares of the company’s stock valued at $1,749,000 after purchasing an additional 122,099 shares during the last quarter. Millennium Management LLC increased its holdings in shares of Clarivate by 1,420.4% in the first quarter. Millennium Management LLC now owns 1,188,978 shares of the company’s stock valued at $4,673,000 after purchasing an additional 1,110,774 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Clarivate by 15.5% in the first quarter. Goldman Sachs Group Inc. now owns 616,250 shares of the company’s stock valued at $2,422,000 after acquiring an additional 82,768 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Clarivate by 13.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,243,683 shares of the company’s stock valued at $4,888,000 after acquiring an additional 144,462 shares in the last quarter. Institutional investors own 85.72% of the company’s stock.

Clarivate Trading Up 0.2%

Shares of Clarivate stock opened at $2.46 on Tuesday. The stock has a fifty day moving average price of $2.52 and a 200-day moving average price of $2.83. Clarivate PLC has a 1 year low of $1.66 and a 1 year high of $4.77. The firm has a market cap of $1.57 billion, a PE ratio of -11.69 and a beta of 1.41. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.84 and a quick ratio of 0.84.

Clarivate (NYSE:CLVT) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.04. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The company had revenue of $585.50 million during the quarter, compared to analyst estimates of $569.50 million. During the same quarter last year, the firm posted $0.14 EPS. The firm’s revenue for the quarter was down 1.4% on a year-over-year basis. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Equities research analysts anticipate that Clarivate PLC will post 0.65 EPS for the current year.

Analyst Upgrades and Downgrades

CLVT has been the subject of several recent analyst reports. Barclays cut their price objective on shares of Clarivate from $4.00 to $2.40 and set an “underweight” rating for the company in a research report on Wednesday, February 25th. Royal Bank Of Canada lowered their price objective on Clarivate from $5.00 to $3.00 and set a “sector perform” rating for the company in a research note on Wednesday, February 25th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Clarivate in a research note on Friday, March 27th. Wall Street Zen raised shares of Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Citigroup reduced their price objective on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating for the company in a research report on Wednesday, March 4th. Five investment analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $3.22.

Clarivate Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.